















Reduce Visible Redness, Calm Reactive Skin and Normalise Sebum Production with a Targeted Rosacea Treatment
ZO Skin Health® Rozatrol is a clinically formulated multi-action treatment serum designed for rosacea-prone, reactive, and chronically red skin. Combining targeted actives that address the key triggers and visible manifestations of rosacea — including persistent redness, visible vascularity, sebum dysregulation, and skin sensitivity — it delivers a comprehensive approach to managing this complex skin condition.
Suitable for all skin types, including sensitive and rosacea-prone skin, it is designed for daily use as part of a supervised skincare programme and is particularly effective when used alongside other ZO Skin Health® treatment products.
Apply a small amount to clean, dry skin, morning and/or evening as directed by your skincare provider. Smooth evenly over affected areas of the face. Allow to absorb fully before applying subsequent products. Follow with SPF 30+ in the morning — UV exposure is a key trigger for rosacea flares.
✔ Those with rosacea-prone skin seeking a clinically formulated daily treatment
✔ Those with persistent facial redness, visible vascularity, or reactive skin
✔ Patients with the sebaceous subtype of rosacea experiencing oiliness and congestion alongside redness
✔ Those looking to complement in-clinic rosacea treatments with an evidence-based at-home regimen
✔ Suitable for use under the guidance of a skincare provider as part of a supervised rosacea management programme
Rozatrol addresses multiple components of rosacea — vascular, sebaceous, and inflammatory — making it a comprehensive management treatment rather than a simple symptom mask. While rosacea is a chronic condition that cannot be cured, consistent use of Rozatrol as part of a supervised programme can significantly reduce the frequency and severity of flares and improve overall skin appearance.
Yes — Rozatrol is designed to complement other ZO Skin Health® treatment products. Your skincare provider will advise on the optimal regimen for your skin, taking into account your rosacea subtype and any other skin concerns.
Reduction in visible redness and skin reactivity is typically noticeable within 4–6 weeks of consistent daily use. More significant improvements in overall skin tone, sebum regulation, and rosacea management develop over 3–6 months of continued use.
No — Rozatrol is suitable for anyone with persistent facial redness, reactive skin, or sebum dysregulation, regardless of formal diagnosis. However, if you suspect you have rosacea, a consultation with a dermatologist or skincare provider is recommended to confirm the diagnosis and develop an appropriate management plan.